Everything below concerns research chemical. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-12. Numbers and descriptions here follow the published literature rather than marketing material.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Synthetic tetrapeptide, four residues |
| Nominal mass | Approximately 390 Da | Free peptide; salt forms differ |
| Appearance | White to off-white powder | Commonly supplied lyophilised |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffer |
| Typical storage | −20 °C, desiccated | Cold packs used during transport |
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
Reversed-phase high-performance liquid chromatography is the standard approach for assessing purity, usually with ultraviolet detection near 214 nm, where the peptide bond absorbs. Mass spectrometry, most often with electrospray ionization, confirms the molecular mass and helps reveal truncation or deletion byproducts. Amino acid analysis can verify composition, and counterion content is sometimes measured because peptides purified with trifluoroacetic acid retain variable amounts of that salt. Purity figures reported without a stated method and detection wavelength are difficult to interpret.
Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.
=== Removal and recovery of polar organics from aqueous streams === Some of King's research has dealt with the removal and recovery of polar organic substances from aqueous streams in two contexts. Research on removal of pollutants by solvent extraction was supported by the U. S. Environmental Protection Agency. He later turned to the use of solvent extraction and adsorption, with and without chemical complexation, for recovery of carboxylic acids, glycols and alcohols from aqueous process streams, such as occur in the manufacture of these chemicals from biomass by fermentation. Much of this work also dealt with novel methods of regeneration of the extractants or adsorbents. The research was sponsored by the U. S. Department of Energy through the Lawrence Berkeley National Laboratory.
These emigrants primarily consisted Trekboers, frontier farmers in the East who had been at the front of the colony's eastward expansion. The emigration became known as the Great Trek and the emigrants Voortrekkers. Details on the various motives behind the Great Trek are laid out in the Voortrekker leader, Piet Retief's 1837 manifesto. The Voortrekkers first moved east into the territory later known as Natal. In 1839, they founded the Natalia Republic as a new Boer homeland. Other Voortrekker parties moved north, settling beyond the Orange and Vaal rivers. Disregarding the Voortrekkers' effortful attempt to claim independence, Britain annexed the Natalia Republic in 1843, which became the Crown colony of Natal. After 1843, British government policy turned strongly against further expansion in South Africa. Although there were some abortive attempts to annex more territories to the north, Britain formally recognised their independence by the Sand River Convention of 1852 and the Orange River Convention of 1854, for the Transvaal and the Orange Free State, respectively.
plasmid Any small DNA molecule that is physically separated from the larger body of chromosomal DNA and can replicate independently. Plasmids are typically small (less than 100 kbp), circular, double-stranded DNA molecules in prokaryotes such as bacteria, though they are also sometimes present in archaea and eukaryotes.
== Further reading == Banting, F.G. & Best, C.H. (1922), "The Internal Secretions of the Pancreas", The Journal of Laboratory and Clinical Medicine, Vol.7, No.5, (February 1922), pp. 251–266. Banting, F.G., Best, C.H., Collip, J.B., Campbell, W.R. & Fletcher, A.A. (1922), "Pancreatic Extracts in the Treatment of Diabetes Mellitus", The Canadian Medical Association Journal, Vol.12, No.3, (March 1922), pp.141–146. US patent no.1,469,994 (held by "Frederick G. Banting and Charles Herbert Best, of Toronto, Ontario, and James Bertram Collip of Edmonton, Alberta, Canada"), (filed: 12 January 1923), (patented: 9 October 1923), for "Extract Obtainable from the Mammalian Pancreas or from the Related Glands in Fishes, Useful in the Treatment of Diabetes Mellitus, and a Method of Preparing it". Henry B. M. Best (2003). Margaret and Charley: The Personal Story of Dr. Charles Best, the Co-Discoverer of Insulin. Dundurn Press Ltd. ISBN 1-55002-399-3. John Waller (2002) Fabulous Science: fact and fiction in the history of scientific discovery, Oxford. See Chapter 11: "Painting yourself into a corner; Charles Best and the discovery of insulin", page 223.
Sources: en.wikipedia.org
In the following decade, Gonzalo Arango founded the movement of "nothingness" in response to the violence of the time; he was influenced by nihilism, existentialism, and the thought of another great Colombian writer: Fernando González Ochoa. During the boom in Latin American literature, successful writers emerged, led by Nobel laureate Gabriel García Márquez and his magnum opus, One Hundred Years of Solitude, Eduardo Caballero Calderón, Manuel Mejía Vallejo, and Álvaro Mutis, a writer who was awarded the Cervantes Prize and the Prince of Asturias Award for Letters.
Greater Manchester Police confirm that, following their investigation, Labour deputy leader Angela Rayner will not face any further police action over her living arrangements before her time as an MP. Former Plaid Cymru MP Jonathan Edwards, who represents Carmarthen East and Dinefwr, announces he will not contest his seat at the election; Edwards was asked to leave Plaid in 2022 after accepting a police caution for assaulting his wife. Stormont passes the 2024 Northern Ireland budget, its first in three years, despite opposition from the Ulster Unionist Party, and the Assembly's official opposition, the Social Democratic and Labour Party. 29 May – MSPs vote 64–0 to exclude Scotland's former health secretary, Michael Matheson, from the Scottish Parliament for 27 sitting days, and to suspend his salary for 54 days, after he breached expenses rules by accumulating an £11,000 bill on his parliamentary iPad. The governing SNP abstains from voting, and calls for a review of the complaints procedure, suggesting it could be open to bias. The Welsh Conservatives table a motion of no confidence in First Minister Vaughan Gething following several weeks of controversy over donations to his leadership campaign. The motion is scheduled to face a Senedd vote on 5 June. Pat Cullen stands down as chief executive of the Royal College of Nursing in order to seek the nomination as Sinn Féin candidate for Fermanagh and South Tyrone in the general election.
== Treatment == A person with cadmium poisoning should seek immediate medical attention, both for treatment and supportive care. For a non-chronic ingestive exposure, emetics or gastric lavage shortly after exposure can beneficially decontaminate the gastrointestinal system. Activated charcoal remains unproven. The US CDC does not recommend chelation therapy, in part because chelation may accentuate kidney damage. For long-term exposure, considerable evidence indicates that the traditional chelator EDTA can reduce a body's overall cadmium load. Co-administered antioxidants, including nephroprotective glutathione, appear to improve efficacy. For patients with extremely fragile kidneys, limited evidence suggests that sauna sweat may differentially excrete the metal.
failure mode and effects analysis (FMEA) manual statistical process control (SPC) manual measurement systems analysis (MSA) manual production part approval process (PPAP) manual APQP serves as a guide in the development process and also a standard way to share results between suppliers and automotive companies. APQP specifies three phases: Development, Industrialization, and Product Launch. Through these phases, 23 main topics will be monitored. These topics must be completed before the production is started. They include the following aspects: design robustness, design testing, and specification compliance, production process design, quality inspection standards, process capability, production capacity, product packaging, product testing, and operator training plan. These activities are sometimes carried out by third-party inspection and quality control companies such as SGS, Bureau Veritas, or QCADvisor, which provide on-site inspections, audits, and testing services to support APQP compliance. APQP focuses on:
The clinical significance of bilirubin glucuronide is involved in many conditions. Drugs that inhibit the activities of the components involved in bilirubin metabolism can give rise to accumulation of bilirubin in the blood. In comparison, conjugation of some drugs is also usually impaired if the liver cannot normally metabolize indirect bilirubin. When excretion of bilirubin glucuronide by the kidney is detected in the urine through urine examination, meaning that a conspicuous amount of conjugated bilirubin is present and circulating in the blood. In Dubin–Johnson syndrome, impaired biliary excretion of bilirubin glucuronide is due to a mutation in the canalicular multiple drug-resistance protein 2 (MRP2). A darkly pigmented liver is due to polymerized epinephrine metabolites, not bilirubin.
Sources: en.wikipedia.org
No. Epithalamin is a heterogeneous peptide fraction obtained from pineal gland extract and contains many components. Epitalon is a single synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. Researchers synthesised the shorter peptide while attempting to identify active sequences within the extract.
No endogenous peptide with this exact sequence has been described as a circulating hormone or signalling molecule. The tetrapeptide was designed as a synthetic analogue based on fragments observed in pineal preparations. Any activity discussed in the literature therefore refers to administered material rather than to a natural pool of the compound.
It is not an approved medicine in major jurisdictions and does not appear in the major pharmacopoeias. Material is usually distributed as a research chemical or laboratory reagent. Such labelling places handling responsibility on the purchaser and does not indicate that a regulatory body has reviewed the substance.
Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.